August 08, 2023
As you know, we took important steps through COVID-19 to deliver timely accommodations to providers and customers, helping to ensure that customers had continued access to COVID-19 diagnostic services, testing, and treatment in safe settings.
How we reimbursed COVID-19 services
As a reminder, we have been reimbursing providers at contracted rates for COVID-19 related services (e.g., vaccine administration, infusion treatments, and testing) only when provider-specific rates were in place for certain COVID-19 services. When no contracted rates were in place, we reimbursed providers for all covered COVID-19 services billed under the medical benefit at the established national Centers for Medicare & Medicaid Services (CMS) rates.
This reimbursement approach was put in place at the onset of the pandemic to ensure that providers received timely, consistent, and reasonable reimbursement.
Updating how we reimburse these services as of August 1, 2023
At the end of the public health emergency period – May 12, 2023 – we communicated that we would continue to follow this reimbursement guidance in the interim while targeting August 1 to pay all providers at contracted rates, including reverting to a default discount for providers who don’t have specifically negotiated rates for COVID-19-related services.
Please note that we are now reimbursing all participating providers at contracted rates for COVID-19-related services beginning with August 1 dates of service (subject to applicable law).
Get the most up-to-date information
Our dedicated COVID-19 provider web page was recently updated to highlight these changes. I encourage you to review this page for the latest information.